Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model.
Katherine A WaughRoss MinterJessica BaxterCongwu ChiMatthew D GalbraithKathryn D TuttleNeetha P EduthanKohl T KinningZdenek AndrysikPaula ArayaHannah DoughertyLauren N DunnMichael LudwigKyndal A SchadeDayna TracyKeith P SmithRoss E GranrathNicolas BusquetSantosh KhanalRyan D AndersonLiza L CoxBelinda Enriquez EstradaAngela L RachubinskiHannah R LyfordEleanor C BrittonKatherine A FantauzzoDavid J OrlickyJennifer L MatsudaKunhua SongTimothy C CoxKelly D SullivanJoaquín Maximiliano EspinosaPublished in: Nature genetics (2023)
Down syndrome (DS), the genetic condition caused by trisomy 21, is characterized by variable cognitive impairment, immune dysregulation, dysmorphogenesis and increased prevalence of diverse co-occurring conditions. The mechanisms by which trisomy 21 causes these effects remain largely unknown. We demonstrate that triplication of the interferon receptor (IFNR) gene cluster on chromosome 21 is necessary for multiple phenotypes in a mouse model of DS. Whole-blood transcriptome analysis demonstrated that IFNR overexpression associates with chronic interferon hyperactivity and inflammation in people with DS. To define the contribution of this locus to DS phenotypes, we used genome editing to correct its copy number in a mouse model of DS, which normalized antiviral responses, prevented heart malformations, ameliorated developmental delays, improved cognition and attenuated craniofacial anomalies. Triplication of the Ifnr locus modulates hallmarks of DS in mice, suggesting that trisomy 21 elicits an interferonopathy potentially amenable to therapeutic intervention.
Keyphrases
- copy number
- mouse model
- mitochondrial dna
- genome editing
- genome wide
- crispr cas
- cognitive impairment
- dendritic cells
- heart failure
- randomized controlled trial
- cell proliferation
- genome wide association study
- immune response
- metabolic syndrome
- binding protein
- multiple sclerosis
- mild cognitive impairment
- type diabetes